FDA Approved: ZOLEDRONIC ACID — Original Application (Mylan Institutional LLC)

View source ↗

Summary

FDA approved an original application for a zoledronic acid generic product manufactured by Mylan Institutional LLC.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Bone Metastases From Solid Tumors
• Breast Cancer with Bone Metastases
• Hypercalcemia of Malignancy
• Osteoporosis
• Paget Disease of Bone
• Prostate Cancer with Bone Metastases

Drugs mentioned

• Zoledronic acid (Zoledronic acid)

Snippet

ORIG AP for ZOLEDRONIC ACID (ZOLEDRONIC ACID)